1. Home
  2. IPWR vs IMMX Comparison

IPWR vs IMMX Comparison

Compare IPWR & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPWR
  • IMMX
  • Stock Information
  • Founded
  • IPWR 2007
  • IMMX 2014
  • Country
  • IPWR United States
  • IMMX United States
  • Employees
  • IPWR N/A
  • IMMX N/A
  • Industry
  • IPWR Industrial Machinery/Components
  • IMMX Medicinal Chemicals and Botanical Products
  • Sector
  • IPWR Industrials
  • IMMX Health Care
  • Exchange
  • IPWR Nasdaq
  • IMMX Nasdaq
  • Market Cap
  • IPWR 56.0M
  • IMMX 61.1M
  • IPO Year
  • IPWR 2013
  • IMMX 2021
  • Fundamental
  • Price
  • IPWR $7.54
  • IMMX $2.24
  • Analyst Decision
  • IPWR Strong Buy
  • IMMX Strong Buy
  • Analyst Count
  • IPWR 1
  • IMMX 1
  • Target Price
  • IPWR $14.00
  • IMMX $7.00
  • AVG Volume (30 Days)
  • IPWR 43.8K
  • IMMX 219.3K
  • Earning Date
  • IPWR 11-14-2024
  • IMMX 11-12-2024
  • Dividend Yield
  • IPWR N/A
  • IMMX N/A
  • EPS Growth
  • IPWR N/A
  • IMMX N/A
  • EPS
  • IPWR N/A
  • IMMX N/A
  • Revenue
  • IPWR $142,107.00
  • IMMX N/A
  • Revenue This Year
  • IPWR $464.18
  • IMMX N/A
  • Revenue Next Year
  • IPWR $809.09
  • IMMX $200.00
  • P/E Ratio
  • IPWR N/A
  • IMMX N/A
  • Revenue Growth
  • IPWR N/A
  • IMMX N/A
  • 52 Week Low
  • IPWR $5.61
  • IMMX $1.26
  • 52 Week High
  • IPWR $13.98
  • IMMX $7.07
  • Technical
  • Relative Strength Index (RSI)
  • IPWR 60.84
  • IMMX 55.23
  • Support Level
  • IPWR $6.76
  • IMMX $2.04
  • Resistance Level
  • IPWR $7.59
  • IMMX $2.44
  • Average True Range (ATR)
  • IPWR 0.52
  • IMMX 0.29
  • MACD
  • IPWR 0.14
  • IMMX -0.02
  • Stochastic Oscillator
  • IPWR 90.52
  • IMMX 46.15

About IPWR Ideal Power Inc.

Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicle, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Share on Social Networks: